DK1495023T3 - Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disse - Google Patents
Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disseInfo
- Publication number
- DK1495023T3 DK1495023T3 DK03730302T DK03730302T DK1495023T3 DK 1495023 T3 DK1495023 T3 DK 1495023T3 DK 03730302 T DK03730302 T DK 03730302T DK 03730302 T DK03730302 T DK 03730302T DK 1495023 T3 DK1495023 T3 DK 1495023T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- new derivatives
- substituted indolizine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0204220A FR2838123B1 (fr) | 2002-04-04 | 2002-04-04 | Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1495023T3 true DK1495023T3 (da) | 2005-12-27 |
Family
ID=28052118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03730302T DK1495023T3 (da) | 2002-04-04 | 2003-04-02 | Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disse |
Country Status (34)
Country | Link |
---|---|
US (2) | US7442708B2 (xx) |
EP (1) | EP1495023B1 (xx) |
JP (1) | JP4741799B2 (xx) |
KR (1) | KR101022138B1 (xx) |
CN (1) | CN100413863C (xx) |
AR (1) | AR040404A1 (xx) |
AT (1) | ATE304013T1 (xx) |
AU (1) | AU2003240984B2 (xx) |
BR (1) | BR0309026A (xx) |
CA (1) | CA2476056C (xx) |
CO (1) | CO5631442A2 (xx) |
DE (1) | DE60301570T2 (xx) |
DK (1) | DK1495023T3 (xx) |
EA (1) | EA007902B1 (xx) |
EC (1) | ECSP045338A (xx) |
ES (1) | ES2247540T3 (xx) |
FR (1) | FR2838123B1 (xx) |
HK (1) | HK1074631A1 (xx) |
HR (1) | HRP20040912B1 (xx) |
IL (2) | IL163755A0 (xx) |
IS (1) | IS2475B (xx) |
MA (1) | MA27297A1 (xx) |
ME (2) | MEP22508A (xx) |
MX (1) | MXPA04009639A (xx) |
NO (1) | NO329025B1 (xx) |
NZ (1) | NZ534786A (xx) |
PL (1) | PL215265B1 (xx) |
RS (1) | RS51399B (xx) |
SI (1) | SI1495023T1 (xx) |
TN (1) | TNSN04188A1 (xx) |
TW (1) | TWI335222B (xx) |
UA (1) | UA78016C2 (xx) |
WO (1) | WO2003084956A1 (xx) |
ZA (1) | ZA200406613B (xx) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
US20070269414A1 (en) * | 2003-11-04 | 2007-11-22 | Shinji Okano | Method for Producing Gene Transferred Denritic Cells |
FR2865934B1 (fr) * | 2004-02-05 | 2006-05-05 | Sanofi Synthelabo | Utilisation de derives d'indolizine 1,2,3 substitues, inhibiteurs des fgfs, pour la preparation de medicaments utiles pour le traitement de maladies liees a une angiogenese pathologique choroidienne |
EP1775343A4 (en) * | 2004-06-24 | 2007-11-14 | Dnavec Research Inc | ANTICANCER AGENTS CONTAINING A DENDRITIC CELL IN WHICH RNA VIRUSES HAVE BEEN TRANSFERRED |
CA2587210A1 (en) * | 2004-11-22 | 2006-06-01 | Threshold Pharmaceuticals, Inc. | Tubulin binding anti cancer agents and prodrugs thereof |
FR2883286B1 (fr) | 2005-03-16 | 2008-10-03 | Sanofi Aventis Sa | NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT |
FR2896247B1 (fr) * | 2006-01-13 | 2008-02-29 | Sanofi Aventis Sa | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique |
EP1891955A1 (en) * | 2006-07-24 | 2008-02-27 | Sanofi-Aventis | Use of 1,2,3-substituted indolizine derivatives, inhibitors of FGFs, for the preparation of a medicament intended for the treatment of degenerative joint diseases |
EP2331541B1 (en) * | 2008-09-04 | 2015-04-22 | Boehringer Ingelheim International GmbH | Indolizine inhibitors of leukotriene production |
WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
EP2270043A1 (en) * | 2009-07-03 | 2011-01-05 | Sanofi-Aventis | Extracellular allosteric inhibitor binding domain from a tyrosine kinase receptor |
CN101648953B (zh) * | 2009-09-24 | 2012-09-05 | 绍兴文理学院 | 一种咪唑并[1,2-b]吡咯并[1,2-f]哒嗪衍生物及其制备方法和用途 |
FR2962437B1 (fr) * | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique |
FR2962438B1 (fr) * | 2010-07-06 | 2012-08-17 | Sanofi Aventis | Derives d'indolizines, procedes de preparation et application en therapeutique |
FR2967412B1 (fr) * | 2010-11-17 | 2012-12-14 | Sanofi Aventis | Nouveaux derives d'indolizine, leur preparation et leur application en therapeutique |
FR2985258A1 (fr) * | 2011-12-28 | 2013-07-05 | Sanofi Sa | Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique |
US10065955B2 (en) * | 2014-12-10 | 2018-09-04 | Ono Pharmaceutical Co., Ltd. | Dihydroindolizinone derivative |
EP3318563A1 (en) * | 2016-11-07 | 2018-05-09 | Sanofi | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders |
CN108864083B (zh) * | 2018-06-07 | 2021-05-25 | 广东药科大学 | 一类具有抗癌活性的氨基取代吲嗪类化合物及其衍生物 |
CN110251513A (zh) * | 2019-07-03 | 2019-09-20 | 南京大学 | 一种含吡唑的中氮茚化合物在制备抗肿瘤药物中的应用 |
US11976066B1 (en) | 2023-10-23 | 2024-05-07 | King Faisal University | Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ193926A (en) * | 1979-07-06 | 1984-05-31 | Labaz Sanofi Nv | 2-(alkyl or phenyl)-3(4-hydroxybenzoyl)indolizines |
US4378362A (en) * | 1979-12-06 | 1983-03-29 | S.A. Labaz N.V. | Indolizine derivatives and process for preparing the same |
FR2528845A1 (fr) * | 1982-06-17 | 1983-12-23 | Sanofi Sa | Nouveaux derives d'indolizine, leur procede de preparation ainsi que les compositions therapeutiques les contenant |
FR2594438B1 (fr) * | 1986-02-14 | 1990-01-26 | Labaz Sanofi Nv | Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant |
GB9318790D0 (en) * | 1993-09-10 | 1993-10-27 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
WO2000071129A1 (en) * | 1999-05-21 | 2000-11-30 | Bristol-Myers Squibb Company | Pyrrolotriazine inhibitors of kinases |
WO2002098876A1 (en) * | 2001-06-06 | 2002-12-12 | Vertex Pharmaceuticals Incorporated | Cak inhibitors and uses thereof |
FR2859997B1 (fr) * | 2003-09-18 | 2006-02-03 | Sanofi Synthelabo | Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant. |
-
2002
- 2002-04-04 FR FR0204220A patent/FR2838123B1/fr not_active Expired - Fee Related
-
2003
- 2003-02-04 UA UA20040807138A patent/UA78016C2/uk unknown
- 2003-03-27 TW TW092106944A patent/TWI335222B/zh not_active IP Right Cessation
- 2003-04-02 DK DK03730302T patent/DK1495023T3/da active
- 2003-04-02 AR AR20030101142A patent/AR040404A1/es active IP Right Grant
- 2003-04-02 AU AU2003240984A patent/AU2003240984B2/en not_active Expired
- 2003-04-02 JP JP2003582153A patent/JP4741799B2/ja not_active Expired - Lifetime
- 2003-04-02 KR KR1020047015666A patent/KR101022138B1/ko not_active IP Right Cessation
- 2003-04-02 NZ NZ534786A patent/NZ534786A/en not_active IP Right Cessation
- 2003-04-02 ME MEP-225/08A patent/MEP22508A/xx unknown
- 2003-04-02 SI SI200330093T patent/SI1495023T1/sl unknown
- 2003-04-02 EP EP03730302A patent/EP1495023B1/fr not_active Expired - Lifetime
- 2003-04-02 WO PCT/FR2003/001030 patent/WO2003084956A1/fr active IP Right Grant
- 2003-04-02 CA CA2476056A patent/CA2476056C/fr not_active Expired - Lifetime
- 2003-04-02 DE DE60301570T patent/DE60301570T2/de not_active Expired - Lifetime
- 2003-04-02 BR BR0309026-4A patent/BR0309026A/pt not_active IP Right Cessation
- 2003-04-02 US US10/509,919 patent/US7442708B2/en not_active Expired - Lifetime
- 2003-04-02 ES ES03730302T patent/ES2247540T3/es not_active Expired - Lifetime
- 2003-04-02 RS YUP-864/04A patent/RS51399B/en unknown
- 2003-04-02 CN CNB038077361A patent/CN100413863C/zh not_active Expired - Lifetime
- 2003-04-02 IL IL16375503A patent/IL163755A0/xx unknown
- 2003-04-02 EA EA200400994A patent/EA007902B1/ru not_active IP Right Cessation
- 2003-04-02 ME MEP-2008-225A patent/ME00118B/me unknown
- 2003-04-02 ZA ZA200406613A patent/ZA200406613B/en unknown
- 2003-04-02 AT AT03730302T patent/ATE304013T1/de active
- 2003-04-02 PL PL372812A patent/PL215265B1/pl unknown
- 2003-04-02 MX MXPA04009639A patent/MXPA04009639A/es active IP Right Grant
-
2004
- 2004-08-19 IS IS7413A patent/IS2475B/is unknown
- 2004-08-26 IL IL163755A patent/IL163755A/en not_active IP Right Cessation
- 2004-09-27 MA MA27876A patent/MA27297A1/fr unknown
- 2004-09-30 NO NO20044156A patent/NO329025B1/no not_active IP Right Cessation
- 2004-09-30 TN TNP2004000188A patent/TNSN04188A1/fr unknown
- 2004-10-01 CO CO04098197A patent/CO5631442A2/es not_active Application Discontinuation
- 2004-10-04 EC EC2004005338A patent/ECSP045338A/es unknown
- 2004-10-04 HR HRP20040912AA patent/HRP20040912B1/hr not_active IP Right Cessation
-
2005
- 2005-10-04 HK HK05108770A patent/HK1074631A1/xx not_active IP Right Cessation
-
2008
- 2008-08-26 US US12/198,545 patent/US7803811B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1495023T3 (da) | Hidtil ukendte derivater af 1,2,3-substitueret indolizin, FGF-inhibitorer, fremgangsmåde for fremstilling og farmaceutiske sammensætninger indeholdende disse | |
HUP0401503A3 (en) | Indole, azaindole and related heterocyclic aminopiperazine derivatives and pharmaceutical compositions containing them | |
DK1163227T3 (da) | Bicykliske heterocykliske forbindelser, farmaceutiske præparater indeholdende disse forbindelser og fremgangsmåder til fremstilling deraf | |
HK1083835A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
HUP0104204A3 (en) | Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof | |
IS7735A (is) | Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær. | |
DK1202965T3 (da) | Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse | |
HUP0303146A3 (en) | 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors and pharmaceutical compositions containing them | |
HK1081964A1 (en) | Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same | |
HK1086485A1 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
DK1560826T3 (da) | Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse | |
AU2003269421A8 (en) | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use | |
NO20042272L (no) | Farmasoytiske blandinger og fremgangsmater for administrering av EP2-reseptor selektive agonister | |
NO20015659D0 (no) | Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse | |
HUP0400317A3 (en) | Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
NO20031396D0 (no) | Derivater av tryptamin og analoge sammensetninger, og farmasöytiske formuleringer som inneholder disse | |
NO20016404L (no) | Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse | |
DK1275647T3 (da) | Octahydro-1H-pyrido[1,2-a]pyrazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
HUP0401280A3 (en) | Pyrimidine derivatives useful as selective cox-2 inhibitors, process for their preparation and pharmaceutical compositions containing them | |
IS6063A (is) | Nýjar morfólínafleiður, aðferð til framleiðslu þeirra og lyfjablöndur sem innihalda þessar afleiður | |
DK1245565T3 (da) | Indenoindolon-forbindelse, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
IS6577A (is) | Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau | |
DK1256583T3 (da) | Pyrimidin-4-on-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
DK1587810T3 (da) | Nye substituerede [1,4]benzodioxino[2,3-e]isoindolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |